Why Roswell Park for Hepatobiliary Cancer - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Why Roswell Park for Hepatobiliary Cancer

  • October 27, 2026

Share

Clinical Scorecard: Why Roswell Park for Hepatobiliary Cancer

At a Glance

CategoryDetail
ConditionLiver and pancreatic cancers; unresectable bile duct cancers; colorectal cancer metastases that cannot be resected or have a high risk of recurrence
Key MechanismsMultidisciplinary specialist evaluation, robotic hepatic artery infusion pump treatment, and robotic Whipple surgery
Target PopulationPatients with liver or pancreatic cancers, unresectable bile duct cancers, or colorectal cancer metastases that cannot be resected or have a high risk of recurrence
Care SettingRoswell Park Comprehensive Cancer Center, which reports performing more than 100 surgeries annually for patients with liver and pancreatic cancers

Key Highlights

  • Roswell Park reports performing more than 100 surgeries for patients with liver and pancreatic cancers each year.
  • Mashaal Dhir, MD, FACS, advises patients to meet with a multidisciplinary team—including medical, radiation and interventional oncologists, surgeons, and interventional gastroenterologists—as early as possible to consider treatment options.
  • Roswell Park says it is the only hospital in its region offering robotic hepatic artery infusion pump treatment.
  • Roswell Park offers robotic Whipple surgery for cancerous and benign conditions; the source says very few centers offer the procedure.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients with bile duct cancers that cannot be removed or colorectal cancer metastases that cannot be resected or pose a high risk of recurrence; the article also describes care for patients with liver and pancreatic cancers.

          The article says robotic hepatic artery infusion pump treatment has been shown to double survival rates and prolong the lives of patients in the specified bile duct and colorectal cancer groups. Dr. Dhir says robotic Whipple surgery can help patients return to regular life and chemotherapy faster.

          Clinical Best Practices

          • Dr. Mashaal Dhir, the center's Section Chief of Upper GI, HBT and Endocrine Surgery, advises early consultation with medical, radiation and interventional oncologists, surgeons, and interventional gastroenterologists to consider available treatment options.

          Related Resources & Content

          Original Source(s)

          Related Content